{"id": "1385155767259570177", "creation": 1619081844.0, "user_id": "98651557", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 13, "reply_count": 0, "like_count": 24, "quote_count": 1}}, "text": "Chief Investigator for the VLA2001-301 program, @adamhfinn, comments on the initiation of the pivotal Phase 3 clinical trial for Valneva's inactivated, adjuvanted #COVID19 #vaccine candidate\nhttps://t.co/k1s1ELvbl3 https://t.co/FYwEKbn89p", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}